Keyphrases
All-cause Mortality
7%
Apixaban
7%
Atrial Fibrillation
100%
Bleeding
15%
Bleeding Risk
7%
Clinical Analysis
7%
Clinical Practice Research Datalink
7%
Concomitant Drug Use
7%
Concomitant Drugs
100%
Confidence Interval
23%
Cox Proportional Hazards Regression
7%
Direct Oral Anticoagulants
100%
Effect Modification
7%
General Practice
7%
Hazard Ratio
23%
Interaction Terms
7%
Ischemic Stroke
15%
Major Bleeding
46%
Mortality Risk
15%
Non-majors
15%
Non-valvular Atrial Fibrillation
7%
Patient Risk
7%
Polypharmacy
30%
Population-wide
7%
Randomized Controlled Trial
7%
Relative Risk
7%
Routine Care
100%
Stroke Risk
7%
United Kingdom
7%
Vitamin K Antagonists
69%
Medicine and Dentistry
All Cause Mortality
7%
Apixaban
7%
Apoplexy
7%
Atrial Fibrillation
100%
Bleeding
15%
Brain Ischemia
15%
Concomitant Drug
100%
Direct Oral Anticoagulant
100%
Drug Use
7%
General Medicine
7%
Hazard Ratio
23%
Major Bleeding
46%
Patient Care
100%
Polypharmacy
30%
Proportional Hazards Model
7%
Randomized Controlled Trial
7%
Vitamin K Antagonist
69%
Pharmacology, Toxicology and Pharmaceutical Science
All Cause Mortality
7%
Antivitamin K
69%
Apixaban
7%
Atrial Fibrillation
100%
Bleeding
61%
Brain Ischemia
15%
Cerebrovascular Accident
7%
Concomitant Drug
100%
Direct Oral Anticoagulant
100%
Polypharmacy
30%
Randomized Controlled Trial
7%